Growth Metrics

Zymeworks (ZYME) Income towards Parent Company (2021 - 2026)

Zymeworks recorded quarterly Income towards Parent Company of -$44.2 million in Q1 2026, down 7.17% quarter-over-quarter from -$41.2 million in Q4 2025, and down 95.1% year-over-year from -$900.6 million in Q1 2025.

Zymeworks' Income towards Parent Company history runs 6 years deep, the most recent figure standing at -$44.2 million for Q1 2026.

  • In Q1 2026, Income towards Parent Company fell 95.1% year-over-year to -$44.2 million; the TTM figure through Mar 2026 stood at -$102.7 million (up 9.7% YoY), while the FY2025 annual figure was -$81.1 million, up 33.88% from the prior year.
  • Income towards Parent Company came in at -$44.2 million for Q1 2026 at Zymeworks, down from -$41.2 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $309.4 million in Q4 2022 to a low of -$72.6 million in Q1 2022.
  • A 5-year average of -$14.3 million and a median of -$29.8 million in 2024 frame the typical range for Income towards Parent Company.
  • Across the five-year window, Income towards Parent Company soared 890.33% in 2022 and tumbled 104.68% in 2023, its largest moves.
  • Zymeworks' Income towards Parent Company stood at $309.4 million in 2022, then sank by 104.68% to -$14.5 million in 2023, then slumped by 62.31% to -$23.5 million in 2024, then sank by 75.31% to -$41.2 million in 2025, then retreated by 7.17% to -$44.2 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$44.2 million, -$41.2 million, and -$19.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Zymeworks 1.84 Bn 1.47 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -44.16 Mn
Dec 31, 2025 -41.21 Mn
Sep 30, 2025 -19.60 Mn
Jun 30, 2025 2.32 Mn
Mar 31, 2025 -22.64 Mn
Dec 31, 2024 -23.51 Mn
Sep 30, 2024 -29.85 Mn
Jun 30, 2024 -37.69 Mn
Mar 31, 2024 -31.65 Mn
Dec 31, 2023 -14.48 Mn
Sep 30, 2023 -28.69 Mn
Jun 30, 2023 -51.15 Mn
Mar 31, 2023 -24.35 Mn
Dec 31, 2022 309.43 Mn
Sep 30, 2022 -47.85 Mn
Jun 30, 2022 -64.62 Mn
Mar 31, 2022 -72.63 Mn
Dec 31, 2021 -39.15 Mn
Sep 30, 2021 -60.58 Mn